Barclays’s NPS PHARMACEUTICALS INC NPSP Stock Holding History

Barclays’s Portfolio NPSP Stock Details NPSP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-205,448	Closed	-$7.19M	–	7496
2014 Q4	$7.19M	Sell	205,448 -57,789	-22%	-$1.73M	0.01%	1413
2014 Q3	$6.84M	Buy	263,237 +252,273	+2,301%	+$7.25M	0.01%	1497
2014 Q2	$363K	Buy	10,964 +466	+4%	+$13.5K	﹤0.01%	4283
2014 Q1	$304K	Sell	10,498 -37,414	-78%	-$1.29M	﹤0.01%	4390
2013 Q4	$1.44M	Sell	47,912 -66,860	-58%	-$1.84M	﹤0.01%	3002
2013 Q3	$3.56M	Buy	114,772 +89,133	+348%	+$2.05M	﹤0.01%	1998
2013 Q2	$387K	Buy	+25,639	New	+$355K	﹤0.01%	4509

Other funds holding NPSP

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

Barclays's NPSP Position: Q1 2015 in Review

Barclays sold out of NPS PHARMACEUTICALS INC (NPSP) in Q1 2015, closing a stake of 205,448 shares — an estimated $7.19M sold.

Barclays first reported a position in NPSP in Q2 2013 and held it in 7 quarters. The position peaked at $7.19M in Q4 2014. 1 fund tracked by Wall St. Rank holds NPSP as of Q1 2015.

Barclays reported no remaining NPS PHARMACEUTICALS INC position as of Q1 2015 after selling out during the quarter.
Barclays sold 205,448 NPS PHARMACEUTICALS INC shares in Q1 2015, an estimated $7.19M.
Barclays first reported a position in NPS PHARMACEUTICALS INC in Q2 2013 and held it in 7 quarters.
Barclays's NPS PHARMACEUTICALS INC position peaked at $7.19M in Q4 2014.
1 fund tracked by Wall St. Rank held NPS PHARMACEUTICALS INC as of Q1 2015.

Based on Barclays's 13F filing for Q1 2015, filed 14 May 2015.